Xbrane Biopharma AB's total assets for Q2 2025 were kr601.79M, a decrease of -13.58% from the previous quarter. DE:7XB total liabilities were kr216.90M for the fiscal quarter, a -54.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.